...
首页> 外文期刊>Journal of clinical gastroenterology >Liver function in cirrhotic patients in the euthyroid versus the hypothyroid state.
【24h】

Liver function in cirrhotic patients in the euthyroid versus the hypothyroid state.

机译:甲状腺功能正常与甲状腺功能低下的肝硬化患者的肝功能。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We recently showed that some decrease in thyroid hormone blood levels can effectively and significantly prevent the development of cirrhosis and fulminant hepatic failure and decrease portal pressure in three different rat models. This study was conducted to determine whether hypothyroidism has a beneficial effect over euthyroidism on patients with active liver cirrhosis of different etiologies. The medical files of hypothyroid patients with cirrhosis who were referred to the Tel-Aviv Medical Center between the years 1980 and 1995 were retrospectively evaluated. Of 3,528 patients with biopsy-proven cirrhosis and 4,738 hypothyroid patients who were identified, only 46 (25 female, 54%; mean age, 52.3 +/- 9.1) met the eligibility criteria. The patients suffered from cirrhosis (mean, 9.5 +/- 4.3 years; range, 4-23) and had hypothyroidism (mean, 12 +/- 6 years; range, 4-31). Most patients suffered from hypothyroidism of unknown etiology (85%), whereas the rest had hypothyroidism after surgical/iodine ablation of the gland. In the hypothyroid versus the euthyroid state, a significant negative correlation was found between thyroid-stimulating hormone blood levels and both functional and synthetic liver function tests (p < 0.001). A significant negative correlation was also found between thyroid-stimulating hormone blood levels and clinical deterioration manifested as bleeding varices, the development of ascites, and episodes of encephalopathy. We conclude that in patients with liver cirrhosis, the liver function in the hypothyroid state tend to be better than in the euthyroid state. A mild controlled decreased thyroid function may be beneficial for euthyroid cirrhotic patients.
机译:我们最近发现,在三种不同的大鼠模型中,甲状腺激素血液水平的某些降低可以有效且显着地预防肝硬化和暴发性肝衰竭的发展,并降低门脉压力。进行这项研究是为了确定甲状腺功能减退症对不同病因的活动性肝硬化患者是否比甲状腺功能减退症有更好的疗效。回顾性评估了1980年至1995年之间转诊至特拉维夫医疗中心的甲状腺功能低下的甲状腺功能减退患者的病历。在确定的3528例经活检证实的肝硬化患者和4738例甲状腺功能减退患者中,只有46例(女性25例,54%;平均年龄52.3 +/- 9.1)符合资格标准。患者患有肝硬化(平均9.5 +/- 4.3岁;范围4-23)和甲状腺功能减退症(平均12 +/- 6岁;范围4-31)。大多数患者患有病因不明的甲状腺功能减退症(85%),而其余患者在手术/碘切除腺体后患有甲状腺功能减退症。在甲状腺功能减退与正常甲状腺状态下,甲状腺刺激激素血液水平与功能和合成肝功能测试之间均存在显着负相关(p <0.001)。还发现甲状腺刺激激素血水平与临床恶化之间存在显着的负相关性,表现为静脉曲张破裂出血,腹水发展和脑病发作。我们得出的结论是,在肝硬化患者中,甲状腺功能减退状态的肝功能往往好于正常甲状腺功能的状态。对甲状腺功能正常的肝硬化患者,轻度控制的甲状腺功能下降可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号